Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis - Wikidata - awgldk - TriplyDB

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q34643194

about

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review Management of multidrug-resistant TB: novel treatments and their expansion to low resource settings Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Delamanid expanded access novel treatment of drug resistant tuberculosis Medical Management of Drug-Resistant Tuberculosis Extensively drug-resistant tuberculosis: epidemiology and management New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda New anti-tuberculosis drugs and regimens: 2015 update Pipeline of drugs for related diseases: tuberculosis Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.Tuberculosis therapy for 2016 and beyond.Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis.In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging Profile of delamanid for the treatment of multidrug-resistant tuberculosis Towards tuberculosis elimination: an action framework for low-incidence countries Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.The role of delamanid in the treatment of drug-resistant tuberculosis.Tuberculosis treatment and drug regimens.Towards early inclusion of children in tuberculosis drugs trials: a consensus statement The need to accelerate access to new drugs for multidrug-resistant tuberculosis.Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes.Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.The multidrug-resistant tuberculosis threat: old problems and new solutions In silico approaches and chemical space of anti-P-type ATPase compounds for discovering new antituberculous drugs.Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis.Physiology, Biochemistry, and Applications of F420- and Fo-Dependent Redox Reactions.Drug-Resistant Tuberculosis: Challenges and Progress.MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration.Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

P2860

Q26741138-AEA2BB69-788F-4372-8CD6-C7C498A630A6 Q26764847-CFEF1297-2A1E-4B10-9DC2-8A93C60291C2 Q26765394-FC35B833-1E48-4C3B-943A-21E2E32CA3E1 Q26771997-996BAAA2-F5AE-470E-96D3-91E2053D3031 Q26775858-3C56ED09-90DE-4CDE-8D0D-DD64B33A003C Q26801601-1A96DD12-E72D-4870-92D0-C1FFF2BF30D0 Q26830094-B89931F1-FEEB-4979-B106-C15EF02A7BF0 Q27003210-2DEA2629-07FB-497A-AB61-B7F4C7EDC22A Q28069032-3EDE52D2-B1E7-4C5A-9833-46F62978CB46 Q28085210-C65FDABA-588B-495A-8A92-98EE29A91583 Q28552438-6C31CEE7-C0D9-431E-8855-D04E3BDB5470 Q28596775-CDF6BF73-A317-4E64-8946-E71DA934301D Q28818217-11B6A076-E61C-417E-891B-4F18F8C61240 Q30236048-88133ECE-5C05-48D5-B895-F009C73B8233 Q30248788-4E96A903-1737-4857-97A5-1F2AD7EA5F6F Q30379233-5046C486-8951-415C-9574-D39D7223577B Q33164956-BD5F8D75-EBAB-4021-A98D-3E2F0F0A8062 Q33760793-2AE8BAF0-5431-4CF2-A10D-A05982C011CB Q33798527-17AC9E0D-FB1E-4BB8-BDA8-B3411C23F65F Q33801345-38235D60-C9AD-4667-8F58-E570B399C19D Q33926262-37DC0133-7DA7-4B36-866F-AD14C27E9900 Q34117376-7FBB629F-3D61-4DF4-A7D0-78B317A9EA9C Q35057495-88702880-4F3E-403A-B9E2-4CEBE074F417 Q35344151-30FB4D30-55D7-4C18-A5F5-33566D3C088B Q35559180-E754EE71-C8DC-49A4-A770-A8DC3AE689BA Q35624245-CBB00F87-50CD-496B-BEDD-6F64B45BA77B Q35663866-AE4544FB-D663-4473-B3F5-E08B693AA0F6 Q35752740-A6E2EE19-DB02-4286-83DF-E08AC7FE6079 Q35815071-1C4920DF-B475-4039-AA3F-024509A771AF Q35933528-BB30AFD2-0A14-474C-9E41-C429AE63D5CC Q35989196-20EAD8C2-F8C1-40F7-B21F-B248FDAA4B8E Q35990643-2C80FBFE-DF5B-466B-8FAB-586658B65796 Q36094215-7B1C76C0-3A19-450F-B37D-B005A3B2AC51 Q36138237-A42053A7-0A23-48E3-BD7F-816EC5BCC6C4 Q36256916-4456AF9F-0E95-4DDA-9292-3F09FFA74DC3 Q36617024-1277C614-CD44-4B42-91AB-65E5E126EB0B Q36902459-D3D6A63C-1A9A-4E13-ABED-E97B60935144 Q36924283-88F237FA-0ED2-4BA8-AD9D-B78331F90851 Q36933353-5BEEA0EB-124E-490D-A046-FA87496F6B1E Q37036566-DAC3FB4B-9A2A-4C86-8BF4-3266F9FD9257

P2860

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q34643194

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@ast

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@en

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@nl

type

label

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@ast

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@en

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@nl

prefLabel

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@ast

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@en

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@nl

P1433

Q34643194-2829FF85-0B81-453C-9D38-B54715A7E1E4

P1476

Q34643194-C331892C-2364-4C99-976C-90B8AE4B2009

P2093

Q34643194-2CFD564C-4983-44BE-BE9A-2606953C5CC5

Q34643194-2D91C2D8-D267-40F3-A7DC-255ABFF71FC8

Q34643194-37715F0D-2503-4F81-B273-AE62EF35FBCA

Q34643194-396C6E81-657C-4F86-861F-AD49FD31702C

Q34643194-3D0EBA44-563E-47DC-B40D-8640F7AE5D7A

Q34643194-4D0E7CF7-5199-4640-AAE7-A69CAB41F3A3

Q34643194-65E5A037-382D-4A23-8BF0-F0B94690BC6D

Q34643194-A3CB3838-A3BC-4850-8886-F6309EFD36FD

Q34643194-A404A417-0738-41DD-9DE7-866D9A4ED378

Q34643194-BDDE8AC7-F26D-4A96-A412-2B973BCE0F6B

P2860

Q34643194-0DE7D0A7-8930-4C5C-94E9-620B8F7C936F

Q34643194-124CD691-B16C-4D0C-9890-2F24CB1973F3

Q34643194-252081EC-9FFE-4F34-9783-F5ADE5A309F2

Q34643194-510AFC43-6FE8-4F27-8703-FFBDE5910243

Q34643194-5D1B6767-82C5-4491-AD2D-4A1523B78E01

Q34643194-61DDE831-1FFA-40EB-8172-E637FFF4E26D

Q34643194-6B4DEAC5-FD9F-46D2-B20B-A07C69C80B50

Q34643194-6C72F5AF-4F06-4E22-981C-1BC30CA8FC90

Q34643194-72A8816F-1A87-4811-A70C-66D257DECE2F

Q34643194-742779EC-655F-4604-8FD5-6B9600A2D9FE

P304

Q34643194-7F412BF0-5816-4125-B86B-D123DA93A074

P31

Q34643194-9F6A5B32-CA3E-4DC1-84BB-B3E038E010CC

P356

Q34643194-1C3C0FCA-8EDC-446D-BAA1-2AD02BDA761B

P433

Q34643194-72059DED-FE75-4C40-8559-A26BF2A9BE51

P478

Q34643194-D03670B9-67DC-47C0-940B-80003C65DBBD

P577

Q34643194-045116F0-1E77-47CB-A94D-A640E52148C0

P5875

Q34643194-56CD9303-9EE9-4A40-ACAE-7F7AA38B9725

P698

Q34643194-BDDE93F5-1B6D-4E90-8173-72654812948A

P921

Q34643194-38A7767B-86B2-4EE6-A823-07ABB70CED88

Q34643194-45D8CCD3-45B4-4506-BCBD-A86ABA00EEEA

P932

Q34643194-17E5D5E0-923B-44FE-B5C7-6DCF1C5B0D59

P356

09031936.00125812

P1433

European Respiratory Journal

P1476

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

@en

P2093

Andra Cirule

http://www.w3.org/2001/XMLSchema#string

Anu Kurve

http://www.w3.org/2001/XMLSchema#string

Charles D Wells

http://www.w3.org/2001/XMLSchema#string

Davide Manissero

http://www.w3.org/2001/XMLSchema#string

Girts Skenders

http://www.w3.org/2001/XMLSchema#string

Klavdia Levina

http://www.w3.org/2001/XMLSchema#string

Lawrence J Geiter

http://www.w3.org/2001/XMLSchema#string

Lea Pehme

http://www.w3.org/2001/XMLSchema#string

Manfred Danilovits

http://www.w3.org/2001/XMLSchema#string

Tarmo Tomson

http://www.w3.org/2001/XMLSchema#string

P2860

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

Delamanid for multidrug-resistant pulmonary tuberculosis

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis

Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.

P304

1393-1400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00125812

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231225097

http://www.w3.org/2001/XMLSchema#string

P698

23018916

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

3669462

http://www.w3.org/2001/XMLSchema#string